Abstract: BackgroundAims." The aim of the present study was to examine the effects of single and repeated administration of 3.4-methylenedioxymethamphetamine (MDMA, "ecstasy") on rat liver. Mefllods." Animals were given an acute (20 mg/kg) and repeated (20 mg/kg, b.i.d., for 4 consecutive day's) intraperitoneal dose of MDMA. and at various times after administration the hepatic and serum determinations were made. Resuhs. The effect of acute MDMA administration included increased triglyceride and cholesterol levels and an increase in all enzyme activities 6 h post administration. The toxic effect of MDMA was also observed in other hepatic processes. Gly'cogen content showed a marked decrease, which was accompanied by' a decrease in serum glucose levels. No significant changes in lipid peroxidation and hepatic GSH content were observed. In con-
opsy, which varied from foci of individual cell necommonly' known as "ecstasy" is a synthetic amcrosis to centrilobular necrosis, hepatitis and exphetamine derivative that rapidly became a widely tensive fibrosis (1 1-13). The principal evidence of abused drug (1). Patented in 1914 by the E. Merck hepatic lesions, resulting from MDMA in humans, Company as an appetite suppressant, it was never is an unexplained jaundice or hepatomegaly (14, marketed, but in the 1970s and early 1980s the 15). Acute hepatitis has also been associated with drug gained popularity as an adjunct to psychorepeated use of ecstasy (16, 17) . therapy (2). Since MDMA's classification in 1985 The aim of the present study was to obtain evias a Schedule I drug under the Controlled Subdence for the mechanism involved in MDMA-instances Act (3), there has been an increase in clanduced hepatotoxicity in rats. For this purpose, sevdestine synthesis and illicit use which has been aceral parameters of rat liver function were detercompanied by an equivalent increase in the nummined. ber of MDMA toxicity reports. MDMA intoxication is predominantly associated with the Materials and methods ability of the drug to destroy serotonergic nerve Drugs used terminals (4-7), but there are some reported cases of severe toxicity resulting from recreational mis-
The MDMA was obtained from the Audiencia use of small amounts of MDMA in which the patProvincial de Navarra. 
Ecstasy-induced injury

Animalsand treatments Measurementof hepatic reducedglutathione(GSH)levels
Male Wistar rats (200-220 g) were housed in plasHepatic GSH content was estimated by a colorimtic cages in a room with a controlled temperature etric method as previously described by Ellman (22°C) and maintained on a 12 h light-dark cycle (21). Samples of liver (0.3 g)were homogenised in 6 with free access to food and water. Two different ml of 10% Trychloroacetic acid, containing 5 mM schedules of treatment with MDMA were used in sodium ethylenediamine tetraacetic acid (EDTA), this study. Acute treatment consisted of a single and later centrifuged at 3000×g for 15 min. The dose of MDMA (20 mg/kg, i.p.), the rats being volume of the supernatants was fixed in 10 ml by sacrificed 3 h and 6 h later. Repeated treatment addition of phosphate buffer (pH 7.4). Aliquots of consisted of the same dose of MDMA (20 mg/kg, 1.0 ml were taken and diluted to 10 ml with phosi.p.) which was given b.i.d, for 4 consecutive days, phate buffer. Then, 3.750 ml of these dilutions was the rats being sacrificed 3 h, 6 h and 7 days later, mixed with a solution of 5,5'-dithiobis-(2-nitrobenThe dose of MDMA (20 mg/kg, i.p.) was chosen zoic acid) (DTNB) (0.08mg/ml in phosphate bufbecause it is in a similar range of doses (10-20 rag/ fer) and incubated in a bath at 37°C for 30 rain. kg) that have been shown to produce neurotoxicity After cooling, the absorbance of each sample was in rats (17). MDMA dose refers to the hydrodetermined at 412 nm, and the GSH concentration chloride. The time points (3 h, 6 h and 7 days) were of these samples was calculated with a standard selected because of the reported neurotoxic effects curve using a dissolution of GSH (0.12 mg/ml) as (18).
standard.
Measurement of antioxidant enzymatic activities: Measurement of lipid peroxidation superoxide dismutase (SOD), glutathione peroxidase (GPx),
The extent of lipid peroxidation, which can be glutathione-S-transferase (GST), glutathi0ne reductase measured by the formation of malondialdehyde (GR)and catalase (CAT) (MDA) after the breakdown of polyunsaturated Animals were sacrificed by decapitation and their fatty acids, was measured by assay for thiobarbitlivers quickly removed and placed in homogenisuric acid reactive substances (TBARS) at 535 rim, ation medium (250 mM mannitol, 70 mM sucrose, as described by Buegue and Aust (19) . Briefly, liver 1 mM EDTA adjusted with Tris to pH 7.4). One samples were homogenised with 50 mM Tris bufpart of the liver was immediately homogenised in a fer, pH 7.5. Then, 2 ml of TBA reagent (0.375% Potter-Elvehjem glass homogeniser (1 g of tissue w/v thiobarbituric acid, 15°/,, w/v trichloroacetic plus 10 ml homogenisation medium). Unbroken acid in 0.25 N HC1) was added to a fraction from cells, cell debris, and nuclei were sedimented at the homogenate samples. The mixture was heated 800×g for 10 min, and the supernatant was used as for 10 min in a boiling water bath, allowed to cool homogenate. This was kept on ice while being soniand then centrifuged at 1000Xg for 10 rain.
cated at 300 w for 30 secondsin three 10 secondsin-TBARS are presented as malondialdehyde equivatervals and centrifuged at 20000x g for 10 min. Alilents, calculated using an extinction coefficient of quots ( 1.0 ml) of the resulting supernatant were pip-1.56×105 M-_/cm -_ etted into plastic tubes, stoppered, and stored at Liver protein content was evaluated by the -70°C until assayed. The enzyme activities of SOD, method of Bradford using bovine serum albumin GR, GPx, GST and CAT were measured using a (BSA) as standard (20).
Cobas MIRA clinical analyser (Roche Diagnostic Systems, Inc., Basel, Switzerland). Analyses, and calculations were performed automatically accordMeasurement of hepatic triglyceridesand cholesterol levels ing to the programmed instructions.
Animals were sacrificed by decapitation and their Assay of serum enzymatic activities and glucose serum livers immediately removed and placed in homogenlevels isation medium (250 mM mannitol, 70 mM sucrose, 1 mM EDTA adjusted with Tris to pH 7.4). One
In order to determine serum transaminase and alpart of the liver was immediately homogenised in a kaline phosphatase activities and glucose serum Potter-Elvehjem glass homogeniser (1 g of tissue levels, animals were anaesthetised using sodium plus 10 ml homogenisation medium). Cholesterol pentobarbital, 50-60 mg/kg body weight, and and triglycerides from this homogenate were measblood samples were removed from the retro-orbital ured by automated assays using Hitachi kits for sinus. The enzymatic activities and glucose levels each determination(HITACHl 704analyser).
were measured by automated enzymatic assays deitia et ai. test), acuteand repeatedMDMAadministration. Acute MDMA treatment caused a significant increase in hepatic triglycerides and cholesterol contenL the using Technicon-Ba,xer kits for each enzyme (Techeffect being significant 6 h after drug injection. Renicon R.A.1000 autoanalyser), pealed administration of MDMA produced a significant increase in cholesterol levels, both 3 h and 6 h after drug administration, which returned to Measurement of hepatic glycogen content control values seven days later. However, no sigHepatic glycogen content was determined accordnificant change in hepatic triglycerides content was ing to the method of McGarry and Kawajima (22) .
observed after repeated MDMA treatment at any' Hepatic samples (0.3 g) were digested with 5 M time of sacrifice (Table 1) . KOH and were precipitated with ethanol. Later, samples were centrifuged at 1000Xg for 15 min.
Effect of MDMA on reduced glutathione (GSH) hepatic An aliquot of the precipitate was mixed with 5 m] content of anthrone reagent (0.05% w/v anthrone, 1% w/v thiourea in sulfuric acid __7"_'" '_,, v/v) . The colour was A single dose of MDMA did not cause any sigdeveloped by' placing the tubes in a boiling bath nificant change in hepatic GSH content. The effect for 10 min. The absorbance of each sample was determined at 620 nm and the glycogenconcen-! tration of these samples was calculated with a stan- of repeated MDMA treatment was more marked. Acute treatment Repeatedtreatment A significant reduction of approximately 22% and 27% in GSH hepatic content was found 3 h and 6 B 240 h respectively after the last injection. Seven days later, hepatic glutathione levels returned to control values ( Fig. 2A) .
180
Effectof MDMAon antioxidant hepaticenzyme activities 8 "_ 120 To establish the mechanism of toxicity as oxygen radical-mediated, there are a number of direct and _ 60 : indirect methods that can be employed. Direct methods include the measurementof superoxide 0 hydrogen peroxide, or hydroxyl radical. These species are very reactive and their quantitation can be Acute treatment Repeatedtreatment difficult. Therefore, indirect methods of study are I',eitia el al. MDMA treatment, glscogen hepatic levels re-A single injection of MDMA significantly inturned to control values (Fig. 3A) . creased ALl-activity 6 h after drug administration.
Serum glucose levels after single or multiple adRepeated MDMA treatment did not elicit an\ sigministration of MDMA are shown in Fig. 3B . nificant change in ALT activity at any time of sac-MDMA caused a substantial reduction in the glurifice, cose levels6 h after a singleinjection.However, MDMA caused a significant increase in ALP acno significant effect on glucose serum levels after ti\it\ at both. 3 h and 6 h after single or repeated repeated MDMA treatment was observed. drug administration.
Furthermore. seven days later. ALP activit\ remained significantl) inHistological examination creased. Figure 4A shows the liver section of a control rat
Effectof MDMAon glycogenhepaticlevelsand glucose
showing, in the centre off the photograph, the portal tract. Striking changes were identified in the serumlevels liver.Acute MDMA treatmentcausedcell necrosis MDMA caused a significant decrease in glycogen particularly in portal areas with inflammatory inhepatic content, the effect being more marked after filtrate consisting in lymphocytes and macro-/-7,,,.4 L.i\cr histology sho\_ ing the portnl lracl in the centre of the photograph. Hepatic necrosis with the portal area being infiltrated by I__mphoc._tcs and macrophagcs following administration off NII)M a, &nimal received saline (control group) (A) or MDMA (20 mg/kg, i.p.) (B) being sacriiiccd 6 hours laler. phages denser in portal tracts, 6 h post administrain peroxidative damage of these lipids (24). Malontion (Fig. 4B) . Figure 5A shows the liver section of dialdehyde, the reaction product of lipid peroxia control rat showing, in the centre of the photodation usually determined in experiments, exerts graph, the hepatic vein. Repeated rejection proseveral biological effects including cross-linking of duced cell necrosis and inflammatory infiltrate proteins and nucleic acids, and is presumably muaround the hepatic _ein. These effects were more tagenic and carcinogenic. Lipid peroxidation and marked 6 h after the last administration (Fig. 5B) subsequent cellular damage are regarded as an inabi,tt seven days later no changes were observed, portant mechanism underlying the toxicity of several xenobiotics (25t. Living organisms contain various free radical Discussion scavenging systems for the clarification of the Hepatotoxicity is one of the medical consequences pathologic role of free radicals, it is therefore esof MDMA consumption (14) . Jaundice, hepatosential to estimate the changes in both the genermegaly, centrilobular necrosis and hepatitis are ation and the scavenging of free radicals. The resome of the MDMA-induced liver conditions (11. duced form of glutathione (GSH), the major intra-14). The most reported form of liver injury is hepacellular thiol, neutralises many kinds of radicals, titis (15) (16) (17) 23) .
either directly or in association witl'lglutathione The mechanism of MDMA-induced hepatic inperoxidase (26). jury is unclear but a spectrum of severity seems to Depletion of GSH, especially in the liver, can exist as assessed by histological changes varying cause irreversible damage and cell death. GSH from mild to moderate lobular hepatitis and to plays an important role in protecting cells against features of massive hepatic parenchymal collapse reactive 02 intermediates and free radicals. Glutawith areas of nodular regeneration. The severity of thione deficiency worsens free radical-induced liver damage does not seem to correlate with either toxicity, while free radical production depletes gluthe amount or frequency of MDMA ingested sugtathione. Decreased ghitathione is an early marker gesting an idiosyncratic type of reaction (13).
of free radical insult and is evident before overt cell In the present study, the major biochemical death occtlrs (27). events indicative of liver injur,<'after acute and re-A single dose of MDMA did not change glutathipeated MDMA administration to rats. wereinxesone levels, and free radical production from tigated. The attack of reactive oxygen species on MDMA was not quantitati,,ely significant enough polyunsaturated fatt\ acids, essential constituents to deplete glutathione and allo,<vuncontrolled reacof biological membranes, has been sho_vn to result tion with ,,ital cclh.llar components.
In contrast, re- Taken together with the present results, the liver changes were observed. In contrast, a significant intoxicity caused by acute MDMA treatment increase in ALT and AST activities, 6 h after drug advolves several mechanisms which cause increased ministration were obtained. Repeated MDMA lipid levels, increased liver enzymes and impaired treatment produced a significant increase ill AST gluconeogenesis leading to a fall ill blood glucose activity but no effect on ALT activity was observed, and depletion of liver glycogen. In contrast reIn all cases, MDMA produced a disproportionate peated treatment produced some evidence of oxiincrease in AST activity compared with ALT activdative stress, namely, increased MDA content and itv. This effect is frequently all index of important decreased GSH content, but no evidence of hecell necrosis. Furthermore, ALP activity as indicapatocyte damage. As far as we know. these results tire of cholestasis was determined.
MDMA caused could be the first major step for research in liver an increase in ALP activity, the effect being more injury'. Furthermore. according to the sympathommarked after a single dose. Seven days after repeated imetic effects reported after acute MDMA mjec-MDMA treatment. ALP activity remained inlion (34), these results could be explained by the creased. These effects resemble those seen in acute effect of the last dose rather than any longhumans in which increases in AST, ALT and ALP terrn chronic effects. activities have been reported (13. 15.29, 301. These findings were corroborated with histological examination which, according to the post-mortem
